{
  "symbol": "A/RES/76/175",
  "filename": "A_RES_76_175.pdf",
  "title": "76/175. Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic",
  "text": "United Nations \nA/RES/76/175\n \n \nGeneral Assembly \nDistr.: General \n10 January 2022 \n \n21-19211 (E)    140122 \n*2119211* \n \n \nSeventy-sixth session \nAgenda item 74 (b) \nPromotion and protection of human rights: human \nrights questions, including alternative approaches for \nimproving the effective enjoyment of human rights and \nfundamental freedoms \n \n \n \n \n Resolution adopted by the General Assembly \non 16 December 2021 \n \n \n \n \n[on the report of the Third Committee (A/76/462/Add.2, para. 114)] \n \n \n 76/175. Ensuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic \n \n \n \nThe General Assembly, \n \nGuided by the purposes and principles of the Charter of the United Nations,  \n \nStressing that States bear the primary responsibility to respect, protect and fulfil \nhuman rights and fundamental freedoms,  \n \nRecalling that one of the purposes of the United Nations is to achieve \ninternational cooperation in solving international problems of an economic, social, \ncultural or humanitarian character and in promoting and encouraging respect for \nhuman rights and fundamental freedoms for all, without distinction of any kind,  \n \nRecalling also the Universal Declaration of Human Rights,1 the International \nCovenant on Civil and Political Rights,2 the International Covenant on Economic, \nSocial and Cultural Rights, 3 the Convention on the Elimination of All Forms of \nDiscrimination against Women, 4 the Convention on the Rights of the Child, 5 the \n__________________ \n \n1  Resolution 217 A (III). \n \n2  See resolution 2200 A (XXI), annex. \n \n3  Ibid. \n \n4  United Nations, Treaty Series, vol. 1249, No. 20378. \n \n5  Ibid., vol. 1577, No. 27531. \n\nA/RES/76/175 \nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic\n \n21-19211\n2/8 \n \nConvention on the Rights of Persons with Disabilities 6  and the International \nConvention on the Elimination of All Forms of Racial Discrimination, 7  \n \nRecalling further other relevant international human rights instruments, \nincluding the Declaration on the Right to Development,8 and the Vienna Declaration \nand Programme of Action, 9  in which it is established that all human rights are \nuniversal, indivisible and interdependent and interrelated,  \n \nReaffirming its resolution 70/1 of 25 September 2015, entitled \u201cTransforming \nour world: the 2030 Agenda for Sustainable Development\u201d, and the Sustainable \nDevelopment Goals enshrined therein, in particular the commitment made by all \nStates to ensure healthy lives and promote well-being for all at all ages, to achieve \ngender equality and to reduce inequalities within and among countries,  \n \nReaffirming also its resolution 69/313 of 27 July 2015 on the Addis Ababa \nAction Agenda of the Third International Conference on Financing for Development, \nwhich is an integral part of the 2030 Agenda for Sustainable Development,  \n \nRecalling its resolutions 74/270 of 2 April 2020, 74/274 of 20 April 2020 and \n74/306 and 74/307 of 11 September 2020, and Human Rights Council resolutions \n41/10 of 11 July 2019,10 44/2 of 16 July 202011 and 46/14 of 23 March 2021,12  \n \nNoting World Health Assembly resolutions 73.1 of 19 May 2020 and 74.7 of \n31 May 2021, as well as World Health Assembly decision 74(16) of 31 May 2021,  \n \nRecalling Security Council resolution 2532 (2020) of 1 July 2020,   \n \nRecognizing the appeals of the Secretary-General concerning the response to the \nimpact of the coronavirus disease (COVID-19) pandemic, with a particular emphasis \non countries in need,   \n \nRecalling the outcome of the high-level meeting on universal health coverage, \nreaffirming its political declaration, entitled \u201cUniversal health coverage: moving \ntogether to build a healthier world\u201d,13 and recognizing further that universal health \ncoverage implies that all people have access, without discrimination, to nationally \ndetermined sets of needed promotive, preventive, curative, palliative and \nrehabilitative essential health-care services and essential, safe, affordable, effective \nand quality medicines, vaccines, therapeutics and diagnostics, while ensuring that the \nuse of these services does not expose users to financial hardship, with special \nemphasis on the poor and other people in vulnerable situations,  \n \nExpressing solidarity with all people and countries affected by the pandemic, \nand condolences and sympathy to the families of the victims of COVID-19 and those \nwhose lives and livelihoods have been affected by the pandemic,  \n \nRecognizing that the availability of vaccines, medicines, health technologies and \nhealth therapies is an essential dimension of the right of everyone to the enjoyment \nof the highest attainable standard of physical and mental health,  \n__________________ \n \n6  Ibid., vol. 2515, No. 44910. \n \n7  Ibid., vol. 660, No. 9464. \n \n8  Resolution 41/128, annex. \n \n9  A/CONF.157/24 (Part I), chap. III. \n \n10  See Official Records of the General Assembly, Seventy-fourth Session, Supplement No. 53 \n(A/74/53), chap. V, sect. A. \n \n11  Ibid., Seventy-fifth Session, Supplement No. 53 (A/75/53), chap. V, sect. A. \n \n12  Ibid., Seventy-sixth Session, Supplement No. 53 (A/76/53), chap. V, sect. A. \n \n13  Resolution 74/2. \n\nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic \nA/RES/76/175\n \n3/8\n21-19211 \n \n \nNoting that, since the beginning of the vaccine roll-out, the majority of all \nvaccines administered have been concentrated in high-income countries, while low-\nincome countries still lag behind in gaining access to COVID-19 vaccines,  \n \nExpressing its serious concern over the disparity between developing countries \nand developed countries in terms of the distribution of COVID-19 vaccines, which \nprevents the entire international community from achieving the complete elimination \nof COVID-19 as soon as possible and also further hampers progress in the realization \nof the 2030 Agenda for Sustainable Development,  \n \nRecognizing the need to tackle health inequities and inequalities within and \namong countries through political commitment, international cooperation and \npolicies, including those that address the social, economic and environmental \ndeterminants of health,  \n \nWelcoming the global initiatives promoting global solidarity in response to the \npandemic, including the efforts of countries that have supplied COVID-19 vaccines, \nand recalling the thirty-first special session of the General Assembly, in response to \nthe COVID-19 pandemic, held on 3 and 4 December 2020, and the high-level meeting \nof the Assembly on universal health coverage, held on 23 September 2019,  \n \nRecognizing that the encouragement and development of international \npartnerships and cooperation in the scientific and cultural fields contribute to the \nrealization of the right of everyone to the enjoyment of the highest attainable standard \nof physical and mental health, bearing in mind that everyone has the right to enjoy \nthe benefits of scientific progress and its applications,  \n \nRecognizing also the importance of international cooperation and effective \nmultilateralism in ensuring that all States, in particular developing States, including \nthe least developed countries, have affordable, timely, equitable and universal access \nto COVID-19 vaccines in order to minimize negative effects in all affected States and \nto avoid the resurgence of the pandemic,  \n \nRecognizing further the important role that civil society, including \nnon-governmental organizations and women\u2019s and community-based organizations, \nyouth-led organizations and all other stakeholders such as volunteers and national \nhuman rights institutions where they exist, as well as the academic and scientific \ncommunity and the private sector play in the response to the COVID-19 pandemic \nand its consequences,  \n \nReaffirming the importance of improving the transparency of markets for \nmedicines, vaccines and other health products across the whole value chain,  \n \nTaking note of the guidance issued by the treaty bodies and the special \nprocedures of the Human Rights Council on States\u2019 human rights obligations in the \ncontext of the COVID-19 pandemic, in particular the statement issued on \n15 December 2020 by the Committee on Economic, Social and Cultural Rights on \nuniversal and equitable access to COVID-19 vaccines14 and the joint statement of \nseveral special procedure mandate holders entitled \u201cUniversal access to vaccines is \nessential for the prevention and containment of COVID-19 around the world\u201d,  \n \nTaking note with appreciation of the guidance note issued on 13 May 2020 by \nthe Office of the United Nations High Commissioner for Human Rights, on human \nrights-compliant responses to the COVID-19 pandemic, and the guidance note issued \nby the Office on 17 December 2020, on human rights and access to COVID-19 \nvaccines,  \n__________________ \n \n14  E/C.12/2020/2. \n\nA/RES/76/175 \nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic\n \n21-19211\n4/8 \n \n \nTaking note of the report of the United Nations High Commissioner for Human \nRights on the impact of the COVID-19 pandemic on the enjoyment of human rights \naround the world, including good practices and areas of concern, 15  \n \nReaffirming the right of everyone to the enjoyment of the highest attainable \nstandard of physical and mental health, which requires that States take the steps \nnecessary to prevent, treat and control epidemic, endemic, occupational and other \ndiseases and to create the conditions that would assure medical services and medical \nattention for all in the event of sickness,  \n \nDeeply concerned about the negative impact of the COVID-19 pandemic on the \nenjoyment of human rights around the world, and emphasizing the importance of \nhuman rights in shaping the response to the pandemic, in terms of both the public \nhealth emergency and the broader impact on people\u2019s lives and livelihoods,  \n \nUnderscoring that equitable access to health products is a matter of global \npriority and that the availability, accessibility, acceptability and affordability of health \nproducts of assured quality are fundamental to tackling the pandemic, and expressing \nits concern about the fact that the unequal distribution of vaccines delays the end of \nthe pandemic,  \n \nReaffirming the fundamental role of the United Nations system in coordinating \nthe global response to control and contain the spread of COVID-19 and in providing \nsupport to States, and in this regard acknowledging the crucial leading role played by \nthe World Health Organization, in line with its constitutional mandate, \n \nEmphasizing the central role of the State in responding to pandemics and other \nhealth emergencies, and the socioeconomic consequences thereof, and in advancing \nsustainable development and the realization of human rights,  \n \nRecognizing the primary responsibility of States to adopt and implement \nresponses to the COVID-19 pandemic that are specific to their national context, and \nthat emergency measures taken by Governments in response to the COVID-19 \npandemic must be necessary, proportionate to the evaluated risk, applied in a \nnon-discriminatory way, have a specific focus and duration and be in accordance with \nStates\u2019 obligations under applicable international human rights law,  \n \nRecognizing also that the COVID-19 pandemic has a disproportionately heavy \nimpact on women, older persons, youth and children, as well as the poor, people in \nvulnerable situations and migrants,  \n \nDeeply concerned about the disproportionate and negative impact of the \nCOVID-19 pandemic on the enjoyment of human rights by women and girls and on \ngender equality worldwide, including due to the increased incidence of domestic \nviolence and interrupted access to sexual and reproductive health, and underscoring \nthe need to ensure a gender-sensitive and people-centred recovery with full respect \nfor human rights, mindful in particular of the need to ensure the full enjoyment by \nwomen and girls of their human rights,  \n \nRecognizing that persons with disabilities face a greater risk of COVID-19 \ninfection and have higher mortality rates, and face aggravated barriers to accessing \nCOVID-19 information, as well as to timely and quality health-care services,  \n \nDeeply concerned that the COVID-19 pandemic perpetuates and exacerbates \nexisting inequalities and that those most at risk are people in vulnerable situations, \nincluding older persons, migrants, refugees, internally displaced persons, persons \nwith disabilities, people living with HIV/AIDS, persons belonging to national or \nethnic, religious and linguistic minorities, local communities, indigenous peoples, \n__________________ \n \n15  A/HRC/46/19. \n\nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic \nA/RES/76/175\n \n5/8\n21-19211 \n \npersons deprived of their liberty, homeless persons and persons living in poverty, and \nrecognizing the need to ensure non-discrimination and equality while stressing the \nimportance of age-responsive and gender- and disability-sensitive measures in this \nregard,  \n \nNoting with concern the uneven access to quality, safe, efficacious and \naffordable COVID-19 vaccines and the difficulties that a large number of countries \nface in gaining access to and supplying them to their populations, stressing the \nimportant role of the Access to COVID-19 Tools (ACT) Accelerator initiative and of \nother relevant initiatives that are aimed at accelerating the development and \nproduction of and equitable access to COVID-19 diagnostics, therapeutics and \nvaccines for all countries and at strengthening health systems, and recognizing in \nparticular the vaccines pillar of the COVID-19 Vaccine Global Access (COVAX) \nFacility, which is aimed at ensuring an equitable global distribution of vaccines to all \nStates,  \n \nRecognizing that the COVID-19 pandemic requires a global response that is \npeople-centred, \ngender-responsive, \nwith \nfull \nrespect \nfor \nhuman \nrights, \nmultidimensional, coordinated, inclusive and innovative, based on unity, solidarity \nand multilateral cooperation, to ensure that all States, in particular developing States, \nincluding the least developed countries, have unhindered, timely, fair and equitable \naccess to safe diagnostics, therapeutics, medicines, vaccines and essential health \ntechnologies and their components, as well as equipment, bearing in mind that \nimmunization against COVID-19 is a global public good for health in preventing, \ncontaining and stopping transmission, and in bringing the pandemic to an end,  \n \nNoting the oral update provided by the United Nations High Commissioner for \nHuman Rights to the Human Rights Council, at its forty-eighth session, on the human \nrights implications of the lack of affordable, timely, equitable and universal access to \nand distribution of COVID-19 vaccines and the deepening inequalities between \nStates, including the related vulnerabilities and challenges and the impact on the right \nof everyone to the enjoyment of the highest attainable standard of physical and mental \nhealth,  \n \nNoting also the Strategy to Achieve Global COVID-19 Vaccination by mid-2022 \ndeveloped by the secretariat of the World Health Organization, which outlines the \nurgent actions required by the global community to vaccinate 40 per cent of the \npopulation of all countries against COVID-19 by the end of 2021 and 70 per cent by \nmid-2022, anchored in the principles of equity, quality, integration and inclusivity,  \n \n1. \nEmphasizes the urgent need to ensure the right of everyone to the \nenjoyment of the highest attainable standard of physical and mental health and to \nfacilitate the development of robust health systems and universal health coverage, \nencompassing universal, timely and equitable access to all essential health \ntechnologies, diagnostics, therapeutics, medicines and vaccines in response to the \nCOVID-19 pandemic and other health emergencies, in order to ensure full access to \nimmunization for all, in particular people in vulnerable situations, as a matter of \nglobal priority for all States;  \n \n2. \nCalls upon States and other relevant stakeholders to take appropriate \nmeasures to guarantee fair, transparent, equitable, efficient, universal and timely \naccess to and distribution of safe, quality, efficacious, effective, accessible and \naffordable COVID-19 vaccines and to enable international cooperation;  \n \n3. \nCalls for the accelerated provision of 550 million more doses of \nCOVID-19 vaccines to the COVID-19 Vaccine Global Access (COVAX) Facility by \nthe end of December 2021 in order to get on track to ensure global access to vaccines \nto face the pandemic;  \n\nA/RES/76/175 \nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic\n \n21-19211\n6/8 \n \n \n4. \nAlso calls for intensified international cooperation and solidarity to \ncontain, mitigate and overcome the pandemic and its consequences, through \nresponses that are people-centred, gender-responsive, multidimensional, coordinated, \ninclusive, innovative, swift and decisive at all levels, with full respect for human \nrights, including by supporting the exchange of information, scientific knowledge and \nbest practices, and enhancing capacity in particular to assist people in vulnerable \nsituations, and the poorest and most vulnerable countries, to build a more equitable, \ninclusive, sustainable and resilient future and to realize the 2030 Agenda for \nSustainable Development;16  \n \n5. \nEncourages States to work in partnership with all relevant stakeholders to \nincrease research and development funding for vaccines, medicines, therapeutics and \ndiagnostics, leverage digital technologies and strengthen the scientific international \ncooperation necessary to combat COVID-19 and to bolster coordination, including \nwith the private sector, towards the further development, manufacturing and \ndistribution of diagnostics, antiviral medicines, therapeutics, personal protective \nequipment and vaccines while adhering to the objectives of quality, efficacy, safety, \nequity, accessibility and affordability;  \n \n6. \nRecognizes the importance of tools to achieve extensive immunization \nagainst COVID-19 as a global public good for health in preventing, containing and \nstopping transmission, and to bring the pandemic to an end, by ensuring the \navailability of safe, quality, efficacious, effective, accessible and affordable vaccines; \n \n7. \nCalls upon States and other relevant stakeholders to remove unjustified \nobstacles restricting the export of COVID-19 vaccines, resulting in an unequal \ndistribution in access thereto between developed and developing countries, and to \npromote the equitable global distribution of and universal access to vaccines, in order \nto further the principles of international cooperation and solidarity, to end the current \npandemic and to promote the realization of the right of everyone to the enjoyment of \nthe highest attainable standard of physical and mental health;  \n \n8. \nUrges States to facilitate the trade in, acquisition of, access to and \ndistribution of COVID-19 vaccines as a crucial element of their responses to the \npandemic, to ensure the right of everyone to the enjoyment of the highest attainable \nstandard of physical and mental health and to support the administration of vaccines \nto address the pandemic, in line with the Sustainable Development Goals and in \naccordance with the relevant international legal frameworks, including international \nhuman rights obligations, taking into account the principles of non-discrimination and \ntransparency;  \n \n9. \nReiterates the call for States to continue to collaborate, as appropriate, on \nmodels and approaches that support the delinking of the cost of new research and \ndevelopment from the prices of medicines, vaccines and diagnostics for diseases, to \nensure their sustained accessibility, affordability and availability and to support \naccess to treatment for all those in need;  \n \n10. Calls upon States and all relevant stakeholders to promote research and \ncapacity-building initiatives and to enhance cooperation on and access to science, \ninnovation, technologies, technical assistance, transfer of technology and knowledge-\nsharing, to ensure universal, equitable and affordable access for all persons to \nCOVID-19 vaccines, including through improved coordination among mechanisms, \nespecially with developing countries, in a collaborative, coordinated and transparent \nmanner and on mutually agreed terms, in response to the COVID-19 pandemic and \ntowards advancing the realization of the Sustainable Development Goals;  \n__________________ \n \n16  Resolution 70/1. \n\nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic \nA/RES/76/175\n \n7/8\n21-19211 \n \n \n11. \nUrges States to leverage digital technologies for the response to \nCOVID-19, including in support of efficient, transparent and robust immunization, \naddressing the socioeconomic impact of COVID-19, paying particular attention to \ndigital inclusion, patient empowerment and the right to privacy and protection of \npersonal data;  \n \n12. Reaffirms the right of States to use, to the fullest extent, the provisions of \nthe World Trade Organization Agreement on Trade-Related Aspects of Intellectual \nProperty Rights (TRIPS Agreement) and the flexibilities therein, as reaffirmed in the \nDoha Declaration on the TRIPS Agreement and Public Health, which recognizes that \nintellectual property protection is important for the development of new medicines \nand also recognizes the concerns about its effects on prices and recognizes further \nthat the Agreement should be interpreted and implemented in a manner supportive of \nthe right of States to protect public health, in particular to promote access to \nmedicines for all, to facilitate access for all to COVID-19 vaccines and to bolster \ncoordination, including with the private sector, towards the rapid development, \nmanufacturing and distribution of vaccines, while adhering to the objectives of \ntransparency, efficacy, safety, equity, accessibility and affordability;  \n \n13. Calls upon States, other partners and donors to urgently support funding \nand close the funding gap for the Access to COVID-19 Tools (ACT) Accelerator and \nits mechanisms, such as the COVAX Facility, to support the equitable distribution of \ndiagnostics, therapeutics and vaccines and to further explore innovative financing \nmechanisms aimed at ensuring affordable, timely, equitable and universal access to, \nand the fair distribution of, COVID-19 vaccines for all and the continuity and \nstrengthening of essential health-care services; \n \n14. Welcomes steps taken to provide a suspension of debt service payments for \nthe poorest countries, and by international financial institutions to provide liquidity \nand other support measures to ease the debt burden of developing countries, and \nencourages all relevant actors, including private and commercial creditors, to address \nrisks of debt vulnerabilities, through existing channels, in developing countries due \nto the pandemic;  \n \n15. Notes the most recent decision of the International Monetary Fund to \nallocate special drawing rights to boost global liquidity and enhance the resilience of \nthe international monetary system, as part of ongoing efforts to support a \ncomprehensive response to and recovery from the COVID-19 pandemic, and, in this \nregard, highlights the call for countries to consider voluntarily channelling unutilized \nspecial drawing rights, in accordance with national laws and regulations, to the \ncountries which are most in need, including the middle-income countries, to better \nsupport sustainable development and a more inclusive recovery, and stresses the \nimportance of ensuring equal access to such resources, to guarantee timely and \nuniversal access to COVID-19 vaccines; \n \n16. Calls upon the international community to continue to assist developing \ncountries in promoting the full realization of the right of everyone to the enjoyment \nof the highest attainable standard of physical and mental health and the right of \neveryone to enjoy the benefits of scientific progress and its applications, including \nthrough access to medicines that are affordable, safe, efficacious and of quality and \nthrough financial and technical support for and training of personnel, while \nrecognizing that the primary responsibility for promoting and protecting all human \nrights rests with States;  \n \n17. Requests all States, international organizations and relevant stakeholders \nto support transparency in all matters relating to the production, distribution and fair \npricing of vaccines, in accordance with national and regional legal frameworks and \ncontexts, and urges States to take immediate steps to prevent speculation and undue \n\nA/RES/76/175 \nEnsuring equitable, affordable, timely and universal access for all \ncountries to vaccines in response to the coronavirus disease \n(COVID-19) pandemic\n \n21-19211\n8/8 \n \nexport controls and stockpiling that may hinder affordable, timely, equitable and \nuniversal access for all countries to COVID-19 vaccines;  \n \n18. Recognizes the immense logistical challenges posed by the lack of \ninfrastructure for the distribution of vaccines in developing countries, including the \nleast developed countries, and calls for greater assistance and building the capacities \nof developing countries, including through effective training programmes in vaccine \ndelivery in this regard;  \n \n19. Strongly urges all States to refrain from taking any economic, financial or \ntrade measures that may adversely affect equitable, affordable, fair, timely and \nuniversal access to COVID-19 vaccines, in particular in developing countries;  \n \n20. Urges Member States to promote an enhanced response to future \npandemics based on experience gained and the lessons learned from the COVID-19 \npandemic and other public health emergencies of international concern, including by \nbuilding, strengthening and maintaining the capacities required under the \nInternational Health Regulations (2005)17 and by supporting the ongoing efforts in \nthe World Health Assembly to consider the benefits of developing a World Health \nOrganization convention, agreement or other international instrument on pandemic \npreparedness and response, while taking into account all the obstacles that impeded \nthe effective response to, and treatment of, the disease as well as the need for all \ncountries to have unhindered access to vaccines and essential health products;  \n \n21. Requests the Secretary-General to report to the General Assembly at its \nseventy-seventh session on the implementation of the present resolution.  \n \n53rd plenary meeting \n16 December 2021 \n \n__________________ \n \n17  World Health Organization, document WHA58/2005/REC/1, resolution 58.3, annex. \n",
  "paragraphs": {
    "1": "Emphasizes the urgent need to ensure the right of everyone to the enjoyment of the highest attainable standard of physical and mental health and to facilitate the development of robust health systems and universal health coverage, encompassing universal, timely and equitable access to all essential health technologies, diagnostics, therapeutics, medicines and vaccines in response to the COVID-19 pandemic and other health emergencies, in order to ensure full access to immunization for all, in particular people in vulnerable situations, as a matter of global priority for all States;",
    "2": "Calls upon States and other relevant stakeholders to take appropriate measures to guarantee fair, transparent, equitable, efficient, universal and timely access to and distribution of safe, quality, efficacious, effective, accessible and affordable COVID-19 vaccines and to enable international cooperation;",
    "3": "Calls for the accelerated provision of 550 million more doses of COVID-19 vaccines to the COVID-19 Vaccine Global Access (COVAX) Facility by the end of December 2021 in order to get on track to ensure global access to vaccines to face the pandemic; A/RES/76/175 Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic 21-19211 6/8",
    "4": "Also calls for intensified international cooperation and solidarity to contain, mitigate and overcome the pandemic and its consequences, through responses that are people-centred, gender-responsive, multidimensional, coordinated, inclusive, innovative, swift and decisive at all levels, with full respect for human rights, including by supporting the exchange of information, scientific knowledge and best practices, and enhancing capacity in particular to assist people in vulnerable situations, and the poorest and most vulnerable countries, to build a more equitable, inclusive, sustainable and resilient future and to realize the 2030 Agenda for Sustainable Development;16",
    "5": "Encourages States to work in partnership with all relevant stakeholders to increase research and development funding for vaccines, medicines, therapeutics and diagnostics, leverage digital technologies and strengthen the scientific international cooperation necessary to combat COVID-19 and to bolster coordination, including with the private sector, towards the further development, manufacturing and distribution of diagnostics, antiviral medicines, therapeutics, personal protective equipment and vaccines while adhering to the objectives of quality, efficacy, safety, equity, accessibility and affordability;",
    "6": "Recognizes the importance of tools to achieve extensive immunization against COVID-19 as a global public good for health in preventing, containing and stopping transmission, and to bring the pandemic to an end, by ensuring the availability of safe, quality, efficacious, effective, accessible and affordable vaccines;",
    "7": "Calls upon States and other relevant stakeholders to remove unjustified obstacles restricting the export of COVID-19 vaccines, resulting in an unequal distribution in access thereto between developed and developing countries, and to promote the equitable global distribution of and universal access to vaccines, in order to further the principles of international cooperation and solidarity, to end the current pandemic and to promote the realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health;",
    "8": "Urges States to facilitate the trade in, acquisition of, access to and distribution of COVID-19 vaccines as a crucial element of their responses to the pandemic, to ensure the right of everyone to the enjoyment of the highest attainable standard of physical and mental health and to support the administration of vaccines to address the pandemic, in line with the Sustainable Development Goals and in accordance with the relevant international legal frameworks, including international human rights obligations, taking into account the principles of non-discrimination and transparency;",
    "9": "Reiterates the call for States to continue to collaborate, as appropriate, on models and approaches that support the delinking of the cost of new research and development from the prices of medicines, vaccines and diagnostics for diseases, to ensure their sustained accessibility, affordability and availability and to support access to treatment for all those in need;",
    "10": "Calls upon States and all relevant stakeholders to promote research and capacity-building initiatives and to enhance cooperation on and access to science, innovation, technologies, technical assistance, transfer of technology and knowledge- sharing, to ensure universal, equitable and affordable access for all persons to COVID-19 vaccines, including through improved coordination among mechanisms, especially with developing countries, in a collaborative, coordinated and transparent manner and on mutually agreed terms, in response to the COVID-19 pandemic and towards advancing the realization of the Sustainable Development Goals; __________________ 16 Resolution 70/1. Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic A/RES/76/175 7/8 21-19211",
    "11": "Urges States to leverage digital technologies for the response to COVID-19, including in support of efficient, transparent and robust immunization, addressing the socioeconomic impact of COVID-19, paying particular attention to digital inclusion, patient empowerment and the right to privacy and protection of personal data;",
    "12": "Reaffirms the right of States to use, to the fullest extent, the provisions of the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and the flexibilities therein, as reaffirmed in the Doha Declaration on the TRIPS Agreement and Public Health, which recognizes that intellectual property protection is important for the development of new medicines and also recognizes the concerns about its effects on prices and recognizes further that the Agreement should be interpreted and implemented in a manner supportive of the right of States to protect public health, in particular to promote access to medicines for all, to facilitate access for all to COVID-19 vaccines and to bolster coordination, including with the private sector, towards the rapid development, manufacturing and distribution of vaccines, while adhering to the objectives of transparency, efficacy, safety, equity, accessibility and affordability;",
    "13": "Calls upon States, other partners and donors to urgently support funding and close the funding gap for the Access to COVID-19 Tools (ACT) Accelerator and its mechanisms, such as the COVAX Facility, to support the equitable distribution of diagnostics, therapeutics and vaccines and to further explore innovative financing mechanisms aimed at ensuring affordable, timely, equitable and universal access to, and the fair distribution of, COVID-19 vaccines for all and the continuity and strengthening of essential health-care services;",
    "14": "Welcomes steps taken to provide a suspension of debt service payments for the poorest countries, and by international financial institutions to provide liquidity and other support measures to ease the debt burden of developing countries, and encourages all relevant actors, including private and commercial creditors, to address risks of debt vulnerabilities, through existing channels, in developing countries due to the pandemic;",
    "15": "Notes the most recent decision of the International Monetary Fund to allocate special drawing rights to boost global liquidity and enhance the resilience of the international monetary system, as part of ongoing efforts to support a comprehensive response to and recovery from the COVID-19 pandemic, and, in this regard, highlights the call for countries to consider voluntarily channelling unutilized special drawing rights, in accordance with national laws and regulations, to the countries which are most in need, including the middle-income countries, to better support sustainable development and a more inclusive recovery, and stresses the importance of ensuring equal access to such resources, to guarantee timely and universal access to COVID-19 vaccines;",
    "16": "Calls upon the international community to continue to assist developing countries in promoting the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health and the right of everyone to enjoy the benefits of scientific progress and its applications, including through access to medicines that are affordable, safe, efficacious and of quality and through financial and technical support for and training of personnel, while recognizing that the primary responsibility for promoting and protecting all human rights rests with States;",
    "17": "Requests all States, international organizations and relevant stakeholders to support transparency in all matters relating to the production, distribution and fair pricing of vaccines, in accordance with national and regional legal frameworks and contexts, and urges States to take immediate steps to prevent speculation and undue A/RES/76/175 Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic 21-19211 8/8 export controls and stockpiling that may hinder affordable, timely, equitable and universal access for all countries to COVID-19 vaccines;",
    "18": "Recognizes the immense logistical challenges posed by the lack of infrastructure for the distribution of vaccines in developing countries, including the least developed countries, and calls for greater assistance and building the capacities of developing countries, including through effective training programmes in vaccine delivery in this regard;",
    "19": "Strongly urges all States to refrain from taking any economic, financial or trade measures that may adversely affect equitable, affordable, fair, timely and universal access to COVID-19 vaccines, in particular in developing countries;",
    "20": "Urges Member States to promote an enhanced response to future pandemics based on experience gained and the lessons learned from the COVID-19 pandemic and other public health emergencies of international concern, including by building, strengthening and maintaining the capacities required under the International Health Regulations (2005)17 and by supporting the ongoing efforts in the World Health Assembly to consider the benefits of developing a World Health Organization convention, agreement or other international instrument on pandemic preparedness and response, while taking into account all the obstacles that impeded the effective response to, and treatment of, the disease as well as the need for all countries to have unhindered access to vaccines and essential health products;",
    "21": "Requests the Secretary-General to report to the General Assembly at its seventy-seventh session on the implementation of the present resolution. 53rd plenary meeting 16 December 2021 __________________ 17 World Health Organization, document WHA58/2005/REC/1, resolution 58.3, annex."
  },
  "agenda_items": [
    "Item 74"
  ],
  "symbol_references": []
}